Arastéh K, Ward D, Plettenberg A, et al. 48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION). Programs and abstracts of the Tenth International Congress on Drug Therapy in HIV Infection; November 7-11, 2010; Glasgow, United Kingdom. Abstract P45.